Thomas Deuel

Thomas Deuel

Presidente presso
Edward R. Mallinckrodt Foundation
91 anni
Consumer Services
Health Technology
Commercial Services

Profilo

Dr. Thomas F.
Deuel
, MD, is Independent Director at Enzon Pharmaceuticals, Inc., a Director-Vascular Biology Affinity Group at The Scripps Research Institute, a Professor-Emeritus at Harvard Medical School, President at Edward R.
Mallinckrodt Foundation, and a Member at Institute of Medicine.
He is on the Board of Directors at Enzon Pharmaceuticals, Inc. Dr. Deuel also served on the board at ImClone Systems, Inc. and Beth Israel Hospital.
Dr. Deuel received his undergraduate degree from Princeton University and a doctorate degree from Columbia University.

Posizioni attive di Thomas Deuel

SocietàPosizioneInizio
Corporate Officer/Principal 01/02/2002
Edward R. Mallinckrodt Foundation
Presidente -
Corporate Officer/Principal 01/01/1998
Corporate Officer/Principal -
Corporate Officer/Principal -

Precedenti posizioni note di Thomas Deuel

SocietàPosizioneFine
Direttore/Membro del Consiglio 22/10/2013
Direttore/Membro del Consiglio 24/11/2008
Corporate Officer/Principal 01/01/2002
Vedi nel dettaglio l'esperienza di Thomas Deuel

Formazione di Thomas Deuel

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

71

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private10

Health Technology

Health Technology

Consumer Services

Health Services

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Edward R. Mallinckrodt Foundation

Consumer Services

  1. Mercati
  2. Insiders
  3. Thomas Deuel